Company Update: Eli Lilly & Company (NYSE:LLY) – U.S. Food and Drug Administration Issues Complete Response Letter for Empagliflozin
March 05, 2014 at 10:28 AM EST
[at noodls] – Boehringer Ingelheim and Lilly are committed to working with the FDA Mar 5, 2014 9:30am RIDGEFIELD, Conn. and INDIANAPOLIS , March 5, 2014 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) . . . → Read More: Company Update: Eli Lilly & Company (NYSE:LLY) – U.S. Food and Drug Administration Issues Complete Response Letter for Empagliflozin Similar Articles: Company Update: Duke Energy Corp (NYSE:DUK) – Power restoration nearly complete after severe storms strike the Carolinas Eli Lilly and Company (NYSE:LLY) – Lilly issues 2014 forecast in line with Wall St estimates Surface RT recovery image released to fix Windows RT 8.1 update issues – Microsoft Corporation (NYSE:MSFT)